The device’s 510(k) application is currently under review by the FDA for market clearance. Pursuant to the agreement, Alphatec Spine will pay an upfront fee over the next 12 months and has agreed to certain minimum purchase commitments.
More Articles on Orthopedic Devices:
10 Orthopedic Device Company Acquisitions
ECA Medical Launches Model 900 Series
Judge: NuVasive May Review Documents to Confirm Employee Poaching By Lanx
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.